An oblique fracture, more specifically. That's what doctors saw on the X-ray of my son's femur.
My son is a walking, talking, energetic boy of 18 months. But a strange string of events at day care last Friday - a twist, the catching of a foot on a table leg, a toppling over - has immobilized him. Doctors put him under, and set him in a spica cast. It's a nearly full-body mummification of both legs, down to the toes, and up the torso, to just under his little arm pits. His legs are splayed open, so he looks a bit like a cowboy who's just gotten off a very fat horse.
Our months-long series about hepatitis C, "At the Crossroads: The Rise of Hepatitis C and the Fight to Stop It," has officially come to an end. We had a great public forum ("Hepatitis C: Cost, Cure, and Challenge") last night at Brown University, the audio from which is posted here, and some key takeaways from which I'll share, below.
Researchers with the Hasbro Children’s Hospital Pediatric Refugee Health Program in Providence have found that the longer child refugees stay in the U.S., the greater the chance they'll become overweight or obese.
It's sinister, this virus: hepatitis C can live in the body for decades before causing any noticeable symptoms. By then, the symptoms could be serious: at the worst, cirrhosis or liver cancer. Most people who have hepatitis C don't know it. In this case, what you don't know can hurt you, or even kill you.
HealthSource RI is out with its most recent enrollment data.
It looks like the state's online health insurance marketplace kept two-thirds (71%) of enrollees from last year and gained a quarter more (about 5,000 new enrollees). So with total enrollments for 2015 at 22,910, HealthSource RI didn't lose a bunch of customers but didn't gain a whole lot either.
At a public hearing yesterday at the Dept. of Health, doctors, dentists, physician assistants, and advanced practice nurses voiced their opposition to the department's proposed regulations governing the prescribing of opioids. The new rules would require prescribers to sign a fairly lengthy agreement with patients, alerting them to the risks of taking prescription painkillers like OxyContin and Vicodin, and agreeing to certain kinds of monitoring. Many health care providers feel these agreements aren't necessary and that, in fact, they're patronizing.
No surprise here: the Philadelphia Transportation Authority is suing Gilead, maker of the expensive new hepatitis C drugs Sovaldi and Harvoni, over the cost of those drugs. A course of Sovaldi, not including drugs you might have to take in combination with it, as some patients do, costs $84,000. Harvoni, which won FDA approval more recently, costs $94,000.
A Rhode Island doctor has just returned from Liberia where for three months he trained health care workers fighting the deadly Ebola virus. Dr. Timothy Flanigan is one of several Rhode Islanders who have traveled to the West African nation to fight the disease that the World Health Organization estimates to have killed some 6500 people.
Shortly after arriving back home, he sat down with me to talk about what he saw and where he sees hope.